
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5835436
[patent_doc_number] => 20060247267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'SNS-595 and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 11/478765
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4003
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20060247267.pdf
[firstpage_image] =>[orig_patent_app_number] => 11478765
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/478765 | Pharmaceutical compositions of (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid | Jun 28, 2006 | Issued |
Array
(
[id] => 4995180
[patent_doc_number] => 20070010525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Method and compositions for modulating neuropeptide hormone secretion'
[patent_app_type] => utility
[patent_app_number] => 11/475010
[patent_app_country] => US
[patent_app_date] => 2006-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7554
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010525.pdf
[firstpage_image] =>[orig_patent_app_number] => 11475010
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/475010 | Method and compositions for modulating neuropeptide hormone secretion | Jun 26, 2006 | Abandoned |
Array
(
[id] => 4995182
[patent_doc_number] => 20070010527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => '4-Anilino-3-quinolinecarbonitriles for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/473540
[patent_app_country] => US
[patent_app_date] => 2006-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5522
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010527.pdf
[firstpage_image] =>[orig_patent_app_number] => 11473540
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/473540 | 4-Anilino-3-quinolinecarbonitriles for the treatment of cancer | Jun 21, 2006 | Abandoned |
Array
(
[id] => 4760026
[patent_doc_number] => 20080312252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Combination of Organic Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/915650
[patent_app_country] => US
[patent_app_date] => 2006-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6394
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312252.pdf
[firstpage_image] =>[orig_patent_app_number] => 11915650
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/915650 | Combination of pyrimidylaminobenzamide compounds and imatinib for treating gastrointestinal stromal tumours | Jun 1, 2006 | Issued |
Array
(
[id] => 4813965
[patent_doc_number] => 20080194596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Therapeutic Combination Including a Selective Erbb2 Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/914924
[patent_app_country] => US
[patent_app_date] => 2006-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27847
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194596.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914924
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914924 | Therapeutic Combination Including a Selective Erbb2 Inhibitor | May 21, 2006 | Abandoned |
Array
(
[id] => 7712561
[patent_doc_number] => 08093295
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-10
[patent_title] => 'Formulations of suberoylanilide hydroxamic acid and methods for producing the same'
[patent_app_type] => utility
[patent_app_number] => 11/663165
[patent_app_country] => US
[patent_app_date] => 2006-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 26524
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/093/08093295.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663165
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663165 | Formulations of suberoylanilide hydroxamic acid and methods for producing the same | May 15, 2006 | Issued |
Array
(
[id] => 5015729
[patent_doc_number] => 20070258937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Deodorizing device'
[patent_app_type] => utility
[patent_app_number] => 11/418334
[patent_app_country] => US
[patent_app_date] => 2006-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4687
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20070258937.pdf
[firstpage_image] =>[orig_patent_app_number] => 11418334
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/418334 | Deodorizing device | May 3, 2006 | Abandoned |
Array
(
[id] => 5149506
[patent_doc_number] => 20070049566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Methods and Compositions for inhibition of angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/411230
[patent_app_country] => US
[patent_app_date] => 2006-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9260
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20070049566.pdf
[firstpage_image] =>[orig_patent_app_number] => 11411230
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/411230 | Methods and compositions for inhibition of angiogenesis | Apr 25, 2006 | Issued |
Array
(
[id] => 5643351
[patent_doc_number] => 20060281806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Treatment and inhibition of disease conditions using flexible heteroarotinoids'
[patent_app_type] => utility
[patent_app_number] => 11/404689
[patent_app_country] => US
[patent_app_date] => 2006-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 17447
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281806.pdf
[firstpage_image] =>[orig_patent_app_number] => 11404689
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/404689 | Treatment and inhibition of disease conditions using flexible heteroarotinoids | Apr 13, 2006 | Abandoned |
Array
(
[id] => 4728109
[patent_doc_number] => 20080207653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Compositions and Method for Increasing the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/910660
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3546
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207653.pdf
[firstpage_image] =>[orig_patent_app_number] => 11910660
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910660 | Compositions and Method for Increasing the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors | Apr 6, 2006 | Abandoned |
Array
(
[id] => 5860042
[patent_doc_number] => 20060229360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Nontoxic potentiation/sensitization of cancer therapy by supplementary treatment with combined Vitamins C and K3'
[patent_app_type] => utility
[patent_app_number] => 11/394311
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5744
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229360.pdf
[firstpage_image] =>[orig_patent_app_number] => 11394311
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/394311 | Nontoxic potentiation/sensitization of cancer therapy by supplementary treatment with combined Vitamins C and K3 | Mar 29, 2006 | Abandoned |
Array
(
[id] => 5875324
[patent_doc_number] => 20060167006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Method of treatment'
[patent_app_type] => utility
[patent_app_number] => 11/386141
[patent_app_country] => US
[patent_app_date] => 2006-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4253
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20060167006.pdf
[firstpage_image] =>[orig_patent_app_number] => 11386141
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/386141 | Method of treatment | Mar 21, 2006 | Abandoned |
Array
(
[id] => 4740612
[patent_doc_number] => 20080234265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Histone Deacetylase Inhibitors Sensitize Cancer Cells to Epidermal Growth Factor Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/908388
[patent_app_country] => US
[patent_app_date] => 2006-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17016
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234265.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908388
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908388 | Histone Deacetylase Inhibitors Sensitize Cancer Cells to Epidermal Growth Factor Inhibitors | Mar 12, 2006 | Abandoned |
Array
(
[id] => 6588778
[patent_doc_number] => 20100061994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'MEDICAL USES OF 39-DESMETHOXYRAPAMYCIN AND ANALOGUES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/908367
[patent_app_country] => US
[patent_app_date] => 2006-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 23174
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20100061994.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908367
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908367 | MEDICAL USES OF 39-DESMETHOXYRAPAMYCIN AND ANALOGUES THEREOF | Mar 9, 2006 | Abandoned |
Array
(
[id] => 10547363
[patent_doc_number] => 09271963
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Selective inhibitors of human corticosteroid synthases'
[patent_app_type] => utility
[patent_app_number] => 11/885605
[patent_app_country] => US
[patent_app_date] => 2006-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 25240
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11885605
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/885605 | Selective inhibitors of human corticosteroid synthases | Mar 1, 2006 | Issued |
Array
(
[id] => 5625996
[patent_doc_number] => 20060264501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Acid containing oxaliplatin formulations'
[patent_app_type] => utility
[patent_app_number] => 11/363542
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10745
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264501.pdf
[firstpage_image] =>[orig_patent_app_number] => 11363542
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/363542 | Acid containing oxaliplatin formulations | Feb 27, 2006 | Abandoned |
Array
(
[id] => 4728114
[patent_doc_number] => 20080207658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Pharmaceutical Combination of Bcr-Abl and Raf Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/909013
[patent_app_country] => US
[patent_app_date] => 2006-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7725
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207658.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909013
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909013 | Pharmaceutical Combination of Bcr-Abl and Raf Inhibitors | Feb 23, 2006 | Abandoned |
| 11/362566 | Pharmaceutical compositions | Feb 23, 2006 | Abandoned |
Array
(
[id] => 123148
[patent_doc_number] => 07705010
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-27
[patent_title] => 'Use of minoxidil sulfate as an anti-tumor drug'
[patent_app_type] => utility
[patent_app_number] => 11/813461
[patent_app_country] => US
[patent_app_date] => 2006-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5766
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/705/07705010.pdf
[firstpage_image] =>[orig_patent_app_number] => 11813461
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813461 | Use of minoxidil sulfate as an anti-tumor drug | Feb 21, 2006 | Issued |
Array
(
[id] => 5656499
[patent_doc_number] => 20060142235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Method of reducing and treating UVB-induced immunosuppression'
[patent_app_type] => utility
[patent_app_number] => 11/358017
[patent_app_country] => US
[patent_app_date] => 2006-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2538
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142235.pdf
[firstpage_image] =>[orig_patent_app_number] => 11358017
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/358017 | Method of reducing and treating UVB-induced immunosuppression | Feb 20, 2006 | Abandoned |